Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound

Sponsor
Medical University of South Carolina (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05792020
Collaborator
BRAINBox Solutions Inc (Industry)
25
1
3
18.6
1.3

Study Details

Study Description

Brief Summary

Through the BrainBox Initiative, we propose to study the effects of motor tFUS on Motor Evoked Potentials (MEPs) and GABA and Glutamate Concentrations in the Brain.

Condition or Disease Intervention/Treatment Phase
  • Device: Focused Ultrasound Stimulation
N/A

Detailed Description

tFUS is an emerging neuromodulatory tool that uses pulses of low-intensity acoustic waves to stimulate deep brain structures such as the thalamus. tFUS has recently been used to probe deep brain structures in unresponsive wakefulness, pain, anxiety, and other neuropsychiatric conditions. However, tFUS is restricted mainly by use in the MR scanner environment, thus limiting session numbers by scan cost and participant comfort. Furthermore, with few human studies to date, the parameter space and mechanisms of action warrant further elucidation. Using novel focused ultrasound methods, we can stimulate at a minimum penetration distance of 20mm, uniquely enabling the study of the neuromodulatory effects of tFUS on cortical tissue. Specifically, we propose to study the effects of motor tFUS on motor-evoked potentials (MEPs) and GABA concentration. The proposed research is critical for understanding tFUS and advancing its therapeutic potential for future clinical trials.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Within-subject, each participant will receive one excitatory course of stimulation and one inhibitory course of stimulation of the motor cortex.Within-subject, each participant will receive one excitatory course of stimulation and one inhibitory course of stimulation of the motor cortex.
Masking:
Double (Participant, Care Provider)
Masking Description:
Device stimulation will be blinded by the outcomes assessor to maintain the blinding of the participants and care provider
Primary Purpose:
Basic Science
Official Title:
Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound (fUS) Over the Motor Cortex
Anticipated Study Start Date :
Jun 15, 2023
Anticipated Primary Completion Date :
Jun 15, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Excitatory tFUS parameters effect on Motor Evoked Potentials

All participants will receive three sessions of Focused Ultrasound Stimulation to their motor hotspot. This stimulation cycle will operate at a 50% duty cycle.

Device: Focused Ultrasound Stimulation
This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.

Experimental: Inhibitory tFUS parameters effect of Motor Evoked Potentials

All participants will receive three sessions of Focused Ultrasound Stimulation to their motor hotspot. This stimulation cycle will operate at a 5% duty cycle

Device: Focused Ultrasound Stimulation
This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.

Sham Comparator: Sham tFUS parameters effect of Motor Evoked Potentials

All participants will receive three sessions of Focused Ultrasound Stimulation to their motor hotspot. This stimulation cycle will utilize an air-filled spacer to block stimulation from reaching the brain

Device: Focused Ultrasound Stimulation
This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.

Outcome Measures

Primary Outcome Measures

  1. Motor Evoked Potential Amplitude [Immediate Post-Stimulation]

    How has the focused ultrasound stimulation affected MEP amplitude

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female

  • Age 18-55

  • Endorse good health with no history of mental or physical illness or implanted metal

  • English as a primary language

  • Capacity to consent

  • Negative urine pregnancy test if a female of childbearing potential

  • Willingness to adhere to the tFUS and MRI study schedule

Exclusion Criteria:
  • Any psychotropic medication is taken within 5 half-lives of procedure time

  • Any head trauma resulting in loss of consciousness

  • Personal or family history of neurological illness or injury

  • Alcohol or substance abuse or dependence (other than tobacco) in the past week

  • Diagnosis or current treatment (pharmacological or otherwise) of any psychiatric condition

  • Pregnancy

  • Personal or family history of seizures or epilepsy

  • Claustrophobia or inability to stay still in the MR scanner environment

  • Any metal in the body

  • Other contraindications to electrical or electromagnetic stimulation

  • Hair in dreadlocks, braids, or weave

  • Diagnosis of COVID-19 in the past 14 days

  • Inability to adhere to the treatment schedule.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of South Carolina Charleston South Carolina United States 29425

Sponsors and Collaborators

  • Medical University of South Carolina
  • BRAINBox Solutions Inc

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kevin Caulfield, Principal Investigator, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT05792020
Other Study ID Numbers:
  • Pro00124327
First Posted:
Mar 30, 2023
Last Update Posted:
Mar 30, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Kevin Caulfield, Principal Investigator, Medical University of South Carolina

Study Results

No Results Posted as of Mar 30, 2023